217 related articles for article (PubMed ID: 37425214)
1. Fragility index of positive phase II and III randomised clinical trials of treatments for hepatocellular carcinoma (2002-2022).
Sidali S; Sritharan N; Campani C; Gregory J; Durand F; Ganne-Carrié N; Ronot M; Lévy V; Nault JC
JHEP Rep; 2023 Jul; 5(7):100755. PubMed ID: 37425214
[TBL] [Abstract][Full Text] [Related]
2. Fragility of results from randomized controlled trials supporting the guidelines for the treatment of osteoporosis: a retrospective analysis.
Huang X; Chen B; Thabane L; Adachi JD; Li G
Osteoporos Int; 2021 Sep; 32(9):1713-1723. PubMed ID: 33595680
[TBL] [Abstract][Full Text] [Related]
3. Frequent fragility of randomized controlled trials for HCC treatment.
Zhang H; Li J; Zeng W
BMC Cancer; 2021 Apr; 21(1):389. PubMed ID: 33836710
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. The fragility of statistical findings in the reverse total shoulder arthroplasty literature: a systematic review of randomized controlled trials.
Yendluri A; Chiang JJ; Linden GS; Megafu MN; Galatz LM; Parsons BO; Parisien RL
J Shoulder Elbow Surg; 2024 Jul; 33(7):1650-1658. PubMed ID: 38281679
[TBL] [Abstract][Full Text] [Related]
6. The Fragility Index of Randomized Controlled Trials for Preterm Neonates.
Li H; Liang Z; Meng Q; Huang X
Front Pediatr; 2022; 10():876366. PubMed ID: 35615631
[TBL] [Abstract][Full Text] [Related]
7. The fragility of phase 3 trials supporting FDA-approved anticancer medicines: a retrospective analysis.
Del Paggio JC; Tannock IF
Lancet Oncol; 2019 Aug; 20(8):1065-1069. PubMed ID: 31296490
[TBL] [Abstract][Full Text] [Related]
8. Fragility of randomised controlled trials for systemic lupus erythematosus and lupus nephritis therapies.
Figueroa-Parra G; Putman MS; Crowson CS; Duarte-García A
Lupus Sci Med; 2024 Jan; 11(1):. PubMed ID: 38199863
[TBL] [Abstract][Full Text] [Related]
9. The Statistical Fragility of Management Options for Acute Achilles Tendon Ruptures - A Systematic Review of Randomized Control Trial with Fragility Analysis.
Doyle TR; Davey MS; Hurley ET
J ISAKOS; 2022 Aug; 7(4):72-81. PubMed ID: 36189473
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Robustness of the Landmark Cardiovascular Outcome Trials of Antidiabetic Drugs - A Systematic Review.
Bose D; Konwar M
Curr Diabetes Rev; 2022; 18(6):e140921196472. PubMed ID: 34521330
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary arterial hypertension trials put to the test: Using the fragility index to assess trials robustness.
Garcia MVF; Coz-Yataco A; Al-Jaghbeer MJ
Heart Lung; 2023; 61():147-152. PubMed ID: 37271106
[TBL] [Abstract][Full Text] [Related]
12. An analysis of randomized controlled trials on anal fistula conducted between 2000 and 2020 based on the Fragility Index and Reverse Fragility Index.
Placer-Galán C; Enriquez-Navascués JM; Lopetegui AE; Ansorena YS
Colorectal Dis; 2023 Aug; 25(8):1572-1577. PubMed ID: 37400967
[TBL] [Abstract][Full Text] [Related]
13. Reexamining the data used in the 2012 guidelines of the American Association for the Study of Liver Diseases for the management of adult patients with ascites due to cirrhosis.
Agrawal R; Majeed M; Attar BM; Omar YA; Chimezi M; Patel P; Kamal S; Demetria M; Gandhi S
Ann Gastroenterol; 2019; 32(6):642-649. PubMed ID: 31700243
[TBL] [Abstract][Full Text] [Related]
14. Fragility Index and Fragility Quotient in Randomized Controlled Trials on Corticosteroids in ARDS Due to COVID-19 and Non-COVID-19 Etiology.
Vargas M; Marra A; Buonanno P; Coviello A; Iacovazzo C; Servillo G
J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830569
[TBL] [Abstract][Full Text] [Related]
15. Statistical robustness of randomized controlled trials in high-impact journals has improved but was low across medical specialties.
Kampman JM; Turgman O; Sperna Weiland NH; Hollmann MW; Repping S; Hermanides J
J Clin Epidemiol; 2022 Oct; 150():165-170. PubMed ID: 35820586
[TBL] [Abstract][Full Text] [Related]
16. Fragility of cardiovascular outcome trials (CVOTs) examining nutrition interventions among patients with diabetes mellitus: a systematic review of randomized controlled trials.
Taouktsi N; Papageorgiou ST; Tousinas G; Papanikolopoulou S; Grammatikopoulou MG; Giannakoulas G; Goulis DG
Hormones (Athens); 2022 Dec; 21(4):665-681. PubMed ID: 36129664
[TBL] [Abstract][Full Text] [Related]
17. Fragility Analysis of Statistically Significant Outcomes of Randomized Control Trials in Spine Surgery: A Systematic Review.
Muthu S; Ramakrishnan E
Spine (Phila Pa 1976); 2021 Feb; 46(3):198-208. PubMed ID: 32756285
[TBL] [Abstract][Full Text] [Related]
18. Assessing the robustness of positive vascular surgery randomized controlled trials using their fragility index.
Javidan A; Benipal H; Vi L; Li A; Lee Y; Feridooni T; Alaichi J; Naji F
J Vasc Surg; 2024 Jan; 79(1):148-158.e3. PubMed ID: 37315910
[TBL] [Abstract][Full Text] [Related]
19. The Fragility of Statistical Findings in Distal Radius Fractures: A Systematic Review of Randomized Controlled Trials.
Megafu M; Megafu E
Injury; 2022 Oct; 53(10):3352-3356. PubMed ID: 35851474
[TBL] [Abstract][Full Text] [Related]
20. The fragility index and reverse fragility index of FDA investigational device exemption trials in spinal fusion surgery: a systematic review.
Proal JD; Moon AS; Kwon B
Eur Spine J; 2024 May; ():. PubMed ID: 38802596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
